SIA "Solepharm"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 277 999 € (25% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2009–2025
| 2009 | 2010 | 2011 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||
| Total current assets | 13 183 | 32 365 | 50 198 | 275 040 | 275 189 | 283 196 | 268 259 | 340 434 | 682 830 | 1 001 531 | 1 376 749 | 1 782 044 | 1 791 142 | 2 032 002 |
| Total non-current assets | 0 | 10 466 | 8372 | 70 967 | 63 631 | 48 137 | 74 337 | 44 004 | 42 386 | 30 664 | 30 729 | 98 141 | 79 080 | 59 946 |
| Total assets | 13 183 | 42 831 | 58 570 | 346 007 | 338 820 | 331 333 | 342 596 | 384 438 | 725 216 | 1 032 195 | 1 407 478 | 1 880 185 | 1 870 222 | 2 091 948 |
| Balance sheet — liabilities and equity | ||||||||||||||
| Current liabilities | 10 457 | 35 603 | 49 636 | 267 300 | 283 709 | 269 426 | 243 254 | 210 754 | 256 238 | 275 990 | 466 461 | 827 295 | 743 721 | 829 878 |
| Non-current liabilities | 0 | 0 | 0 | 32 018 | 26 587 | 21 300 | 36 574 | 26 245 | 15 375 | 3942 | 0 | 42 321 | 32 390 | 20 881 |
| Total liabilities | 10 457 | 35 603 | 49 636 | 299 318 | 310 296 | 290 726 | 279 828 | 236 999 | 271 613 | 279 932 | 466 461 | 869 616 | 776 111 | 850 759 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 673 | 4467 | 1567 | 5789 | -15 356 | 84 | 16 381 | 91 058 | 306 164 | 279 064 | 188 754 | 314 157 | 383 542 | 425 077 |
| Total equity | 2673 | 7140 | 8707 | 46 366 | 28 524 | 40 607 | 62 768 | 147 439 | 453 603 | 752 263 | 941 017 | 1 010 569 | 1 094 111 | 1 241 189 |
| Income statement | ||||||||||||||
| Sales revenue | 29 097 | 65 877 | 137 686 | 809 906 | 1 005 017 | 1 063 471 | 1 229 814 | 1 564 830 | 2 166 693 | 2 060 074 | 3 258 316 | 4 049 743 | 4 110 535 | 5 240 842 |
| Operating profit | 804 | 4776 | 2007 | 9176 | -11 469 | 6563 | 21 719 | 94 571 | 308 262 | 280 764 | 190 592 | 315 883 | 461 927 | 499 822 |
| Profit before income tax | 802 | 4770 | 1915 | 5789 | -15 055 | 3566 | 17 773 | 91 651 | 306 183 | 279 076 | 189 450 | 314 198 | 458 803 | 497 937 |
| Profit for the reporting year | 673 | 4467 | 1567 | 5789 | -15 356 | 84 | 16 381 | 91 058 | 306 164 | 279 064 | 188 754 | 314 157 | 383 542 | 425 077 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||||
| Employees | 3 | 3 | 3 | 4 | 5 | 5 | 10 | 8 | 8 | 10 | 13 | 11 | 10 | 11 |
| Calculated dividend | — | 0 | 0 | — | 2486 | 0 | 0 | 6387 | 0 | 0 | 0 | 244 605 | 300 000 | 277 999 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA "Solepharm"
Overview
SIA "Solepharm" (reg. no. 40103209086) is a limited liability company. The company was registered in 2009 and has been in the register for 17 years. Registered address: Mārupes nov., Mārupes pag., Jaunmārupe, Alkšņu iela 4.
Financial results
Revenue in 2025 was 5 240 842 €, up 27,5% on the previous year (4 110 535 €). From 2009 to 2025, revenue grew by an average of 49,1% per year. This is the company's highest revenue among the published years (2009–2025). Net profit for 2025 was 425 077 € (8,1% of revenue). The company was profitable in 13 of the 14 published years. In 2025 the company had 11 employees (10 a year earlier). Revenue per employee was 476 440 €. At the end of 2025, total assets were 2 091 948 € and equity 1 241 189 € (59,3% of assets).
Management and owners
The company has one board member. The sole owner of the company is SIA "Solepharm Pharmaceuticals".
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.